CLS Holdings USA, Inc. Outpaces Statewide Market Growth with Category Leadership
LAS VEGAS, NV / ACCESSWIRE / November 17, 2020 / CLS Holdings USA, Inc. (OTCQB:CLSH) (CSE:CLSH), the ''Company'' or ''CLS'',...
Month: November 2020
Chiesi USA, Inc. Supports March of Dimes Eastern North Carolina in Observance of Prematurity Awareness Month
CARY, N.C., Nov. 17, 2020 (GLOBE NEWSWIRE) -- Chiesi USA (key-ay-zee), a specialty pharmaceutical company based in Cary, N.C., is...
MedLite ID Welcomes Vice President of Sales, Accelerating Its Growth and Expansion Plans
ST. GEORGE, Utah, Nov. 17, 2020 (GLOBE NEWSWIRE) -- MedLite ID is very pleased to announce healthcare sales veteran, Bruce...
Tecan to present at upcoming Investor Conferences
Tecan to present at upcoming Investor Conferences Männedorf, Switzerland, November 17, 2020 – The Tecan Group (SIX Swiss Exchange: TECN)...
OmniPathology Launches OmniClassroom, a COVID School Testing Program for Greater Los Angeles Schools
PASADENA, Calif., Nov. 17, 2020 (GLOBE NEWSWIRE) -- OmniPathology today launches its school COVID PCR testing program, OmniClassroom. As schools...
StrideCare Unifies all Practices on athenahealth to Support Rapid Growth and Optimize Operations
Technology migration during COVID-19 pandemic improves workflow efficiency and patient outcomes WATERTOWN, Mass., Nov. 17, 2020 (GLOBE NEWSWIRE) -- athenahealth,...
Syneos Health Names Larry A. Pickett Jr. Chief Information & Digital Officer
MORRISVILLE, N.C., Nov. 17, 2020 (GLOBE NEWSWIRE) -- Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced...
Fluidigm COVID-19 Community Connect Program Builds a Network of Testing Partners to Increase Access of Saliva-Based SARS-CoV-2 Testing for Communities
SOUTH SAN FRANCISCO, Calif., Nov. 17, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision...
Brain Scientific Aims to Expand into the EU Market, Retains Registration Firm in Europe
NEW YORK, Nov. 17, 2020 (GLOBE NEWSWIRE) -- via InvestorWire – Brain Scientific Inc. (OTCQB: BRSF), a neurology-focused medical device...
Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08
BASEL, Switzerland, Nov. 17, 2020 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE: MYOV), a healthcare company focused on redefining care for women and...
Enlivex Appoints Former ArQule, Inc. Executive Dr. Brian Schwartz to the Company’s Board of Directors
* Dr. Schwartz Served as ArQule’s Chief Medical Officer and Head of Research and Development Prior to the $2.7 billion...
Genetic Technologies to Hold Investor Webinar and Q&A Session on November 19
MELBOURNE, Australia, Nov. 17, 2020 (GLOBE NEWSWIRE) -- Molecular diagnostics company Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE, “Company”) is pleased...
Athenex Announces Data on Oral Paclitaxel and Encequidar to be Presented at the 2020 San Antonio Breast Cancer Symposium (SABCS)
Spotlight poster on updated PFS and OS data from the pivotal Phase 3 clinical trial of oral paclitaxel in metastatic...
Ayala Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Business Update
- Presented New Positive Interim Data from 4mg Cohort of Phase 2 ACCURACY Study of AL101 for the Treatment of...
Nemaura Medical Launches BEAT™diabetes Program Through New Web Presence and Re-Launches Enhanced Corporate Website
LOUGHBOROUGH, England, Nov. 17, 2020 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company...
Milestone Scientific Reports Seven-Fold Sequential Increase in Dental Sales for Q3 2020 Versus Q2 2020
ROSELAND, N.J., Nov. 17, 2020 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery...
EDAP Announces Exclusive Distribution Agreement with Leading Italian Medical Device Distributor AB Medica
Partnership further extends the availability of EDAP’s High Intensity Focused Ultrasound (HIFU) technology to one of the largest markets in...
Mydecine Innovations Group Offers Management and Clinical Trials Update
Dr. Rakesh Jetly Appointed Chief Medical Officer Company Announces International Expansion of Clinical Trial Sites for Phase 2A Study into...
AzurRx BioPharma Requests Protocol Amendment to Phase 2b OPTION 2 Study of MS1819 in Cystic Fibrosis Patients
Potential to add additional study arm utilizing immediate release capsules Trial objectives, endpoints and statistical analysis to remain the same...
BioSyent Schedules Q3 and YTD 2020 Earnings Release for November 26, 2020
MISSISSAUGA, Ontario, Nov. 17, 2020 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its...